The present invention provides compounds of formula I, and pharmaceutically acceptable salts thereof. The formula I compounds inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2 and FGFR-1, thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors.

 
Web www.patentalert.com

< Urinary catheter device with a pharmaceutically active composition

< Severe sepsis preventive therapeutic agent

> [1,2,4] Triazolo[1,5-c]pyrimidine derivatives

> Use of papaverine-like vasodilator and pharmaceutical composition

~ 00246